Levine Mark S. has filed 17 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 3650 shares of Immunovant, Inc. ($IMVT) on November 20, 2024.
Activity breakdown: 0 open-market purchases and 15 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3650 | $25.45 | 319,228.0000 | 0 | 1.13% | 0.00% |
| Oct. 23, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 4361 | $29.53 | 322,878.0000 | 0 | 1.33% | 0.00% |
| Oct. 16, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2860 | $28.79 | 327,239.0000 | 0 | 0.87% | 0.00% |
| Aug. 21, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3164 | $31.84 | 330,230.0000 | 0 | 0.95% | 0.00% |
| Aug. 21, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 131 | $32.32 | 330,099.0000 | 0 | 0.04% | 0.00% |
| July 24, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 4015 | $27.76 | 333,394.0000 | 0 | 1.19% | 0.00% |
| July 17, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2358 | $29.64 | 337,556.0000 | 0 | 0.69% | 0.00% |
| July 17, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 147 | $30.55 | 337,409.0000 | 0 | 0.04% | 0.00% |
| May 22, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3242 | $29.65 | 339,914.0000 | 0 | 0.94% | 0.00% |
| April 24, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3963 | $28.90 | 343,156.0000 | 0 | 1.14% | 0.00% |
| April 17, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 7602 | $28.80 | 349,344.0000 | 0 | 2.13% | 0.00% |
| April 17, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2225 | $29.94 | 347,119.0000 | 0 | 0.64% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | A | Common Stock | 54978 | $0.00 | 356,946.0000 | 0 | 18.21% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2134 | $36.15 | 301,968.0000 | 0 | 0.70% | 0.00% |
| Jan. 26, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2981 | $37.91 | 304,148.0000 | 0 | 0.97% | 0.00% |
| Jan. 26, 2024 | Immunovant, Inc. | $IMVT | Levine Mark S. | Chief Legal Officer | S | Common Stock | 46 | $38.45 | 304,102.0000 | 0 | 0.02% | 0.00% |